It is definitely worth the risk to trial this.
yes it may cost our x amount supplying the product to be tested, there may even be an agreement for them to buy some for the trial, we do not know.
though it is worth the risk isn't it? If we can enter this market it would be huge.
if the company dropped a CR for a trail like this I would be 100% supportive. If the trail was unsuccessfully I wouldn't care, they had a crack trying to enter a market dominated by chemicals.
- Forums
- ASX - By Stock
- Ann: Natshield to be trialled by intelligent sterilisation robots
It is definitely worth the risk to trial this.yes it may cost...
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HCT (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.286M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 375610 | 1.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.9¢ | 400000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 375610 | 0.015 |
1 | 100000 | 0.010 |
1 | 3000000 | 0.009 |
1 | 45000 | 0.005 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.019 | 400000 | 1 |
0.021 | 25000 | 1 |
0.028 | 49999 | 1 |
0.029 | 78000 | 2 |
0.030 | 22000 | 2 |
Last trade - 16.12pm 12/11/2024 (20 minute delay) ? |
Featured News
HCT (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online